About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1477 record(s)
Req # A-2022-000829
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-105463-500.Organization: Health Canada
November 2022
Req # A-2022-000830
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107213-827.Organization: Health Canada
November 2022
Req # A-2022-000839
Adverse Drug Reactions (ADRs) for SINGULAIR. Report numbers: E2B_01326513, E2B_01346264, E2B_01361119, E2B_01366170, E2B_01376304, 000703449, E2B_01320127, E2B_01338548, E2B_01346788, E2B_01354574.Organization: Health Canada
November 2022
Req # A-2022-000844
Adverse Drug Reactions (ADRs). Report numbers: E2B_05562798, E2B_05538380, E2B_05499967.Organization: Health Canada
November 2022
Req # A-2022-000846
Adverse Drug Reactions (ADRs) for SINGULAIR. Report numbers: E2B_01279129, E2B_01326513.Organization: Health Canada
November 2022
Req # A-2022-000857
Adverse Drug Reactions (ADRs). Report numbers: E2B_05041561, E2B_05041555, E2B_05040714, E2B_05040718, E2B_05040719, E2B_05040680, E2B_05040722, E2B_05040727, E2B_05040730, E2B_05040731.Organization: Health Canada
November 2022
Req # A-2022-000858
Adverse Drug Reactions (ADRs). Report numbers: E2B_05040732, E2B_05041550, E2B_05041543, E2B_05040734, E2B_05041534 E2B_05040736 E2B_05041533 E2B_05040737 E2B_05040738 E2B_05041531.Organization: Health Canada
November 2022
Req # A-2022-000863
Adverse Drug Reactions (ADRs). Report numbers: E2B_05045989, E2B_05046158, E2B_05046455, E2B_05046725, E2B_05045988, E2B_05046103, E2B_05046731, E2B_05046442, E2B_05047205, E2B_05047244.Organization: Health Canada
November 2022
Req # A-2022-000866
Adverse Drug Reaction (ADR). Report number: 001003172.Organization: Health Canada
November 2022
Req # A-2022-000867
Adverse Drug Reaction (ADR). Report number: E2B_05512952.Organization: Health Canada
November 2022